<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
        <title>JBJI - recent articles</title>


    <link rel="self" href="https://jbji.copernicus.org/articles/"/>
    <id>https://jbji.copernicus.org/articles/</id>
    <updated>2026-11-15T23:19:49+01:00</updated>
    <author>
        <name>Copernicus Publications</name>
    </author>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-705-2026</id>
            <title type="html">A pre-specified surgical-complexity index is associated with a graded increase in periprosthetic joint infection after total knee arthroplasty: a competing-risks analysis using coronal alignment as a negative control
            </title>
            <link href="https://doi.org/10.5194/jbji-11-705-2026"/>
            <summary type="html">
                &lt;b&gt;A pre-specified surgical-complexity index is associated with a graded increase in periprosthetic joint infection after total knee arthroplasty: a competing-risks analysis using coronal alignment as a negative control&lt;/b&gt;&lt;br&gt;
                Wayne Hoskins, Charles Gusho, Kenrick Rosser, Matthew Lim, Kate Dunstall, and Kelly G. Vince&lt;br&gt;
                    J. Bone Joint Infect., 11, 705&#8211;713, https://doi.org/10.5194/jbji-11-705-2026, 2026&lt;br&gt;
                <p dir="auto">Infection after knee replacement is usually blamed on the patient. We asked whether the operation itself matters. In 2920 knee replacements from one New Zealand hospital, each added feature of a complex operation, such as a previous implant, a bone deformity or a larger, stemmed implant, raised the risk of later infection by about 60&amp;#8201;%. Leg alignment, which affects wear and loosening, did not change infection risk. Surgeons should weigh how complex the operation will be when judging this risk.
            </summary>
            <content type="html">
                &lt;b&gt;A pre-specified surgical-complexity index is associated with a graded increase in periprosthetic joint infection after total knee arthroplasty: a competing-risks analysis using coronal alignment as a negative control&lt;/b&gt;&lt;br&gt;
                Wayne Hoskins, Charles Gusho, Kenrick Rosser, Matthew Lim, Kate Dunstall, and Kelly G. Vince&lt;br&gt;
                    J. Bone Joint Infect., 11, 705&#8211;713, https://doi.org/10.5194/jbji-11-705-2026, 2026&lt;br&gt;
                <p>Prediction of periprosthetic joint infection (PJI) after total knee arthroplasty (TKA) relies almost wholly on host factors, and whether the operation itself carries infection risk independent of the patient is unknown. We analyzed 2920 primary TKAs in 2350 patients from a single institution with national joint registry linkage, using death as a competing risk and coronal alignment as a negative-control exposure. A pre-specified surgical-complexity index counted five construct markers at the index operation: constraint, a tibial stem, a femoral stem, a previous implant and a pre-existing extra-articular deformity or fracture. Septic revision was the primary outcome and aseptic revision the control. Fine&amp;#8211;Gray subdistribution hazard models with patient-level clustering estimated complexity and, in the paired-radiograph subset, neutral-alignment effects on both outcomes. There were 51 septic and 104 aseptic revisions and 525 deaths over a median follow-up of 7.4 years. Each additional complexity marker raised the subdistribution hazard of PJI (sHR 1.61, 95% CI 1.27&amp;#8211;2.04) but not of aseptic revision (sHR 1.06, 95% CI 0.84&amp;#8211;1.33); 5-year PJI incidence rose from 1.5% with zero or one marker to 5.9% with two or more. Neutral coronal alignment was protective against aseptic revision (sHR 0.42, 95% CI 0.26&amp;#8211;0.67) but null for PJI (sHR 0.87, 95% CI 0.41&amp;#8211;1.87). Adjustment for skin-to-skin operative time, available for 93% of the cohort, moved the complexity estimate in the same knees only from&amp;#160;1.58 to&amp;#160;1.55 and attributed 5&amp;#8201;% of the effect to operative time. These are observational associations and not causal effects, but surgical exposure merits consideration alongside host factors in infection-risk assessment.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-11-11T23:19:49+01:00</published>
            <updated>2026-11-11T23:19:49+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-687-2026</id>
            <title type="html"><i>Corrigendum to</i> &#8220;Differential synovial fluid white blood cell count for the diagnosis of chronic peri-prosthetic joint infection &#8211; a systematic review and meta-analysis&#8221; published in J. Bone Joint Infect., 10, 165&#8211;184, 2025
            </title>
            <link href="https://doi.org/10.5194/jbji-11-687-2026"/>
            <summary type="html">
                &lt;b&gt;Corrigendum to “Differential synovial fluid white blood cell count for the diagnosis of chronic peri-prosthetic joint infection – a systematic review and meta-analysis” published in J. Bone Joint Infect., 10, 165–184, 2025&lt;/b&gt;&lt;br&gt;
                Marta Sabater-Martos, Benjamin Langworthy, Martin Clauss, Ana Ribau, Ricardo Sousa, and and on behalf of the Leukocyte Count Synovial Fluid working group for the Unified PJI definition task force&lt;br&gt;
                    J. Bone Joint Infect., 11, 687&#8211;704, https://doi.org/10.5194/jbji-11-687-2026, 2026&lt;br&gt;
                This meta-analysis evaluates synovial fluid white blood cell count and polymorphonuclear neutrophil proportion in order to diagnose chronic peri-prosthetic joint infection. Based on 74 studies, it identifies optimal thresholds for both test. Confounding factors such as fractures and inflammatory arthritis are addressed. The findings support standardized diagnostic frameworks in improving accuracy and clinical consistency.
            </summary>
            <content type="html">
                &lt;b&gt;Corrigendum to “Differential synovial fluid white blood cell count for the diagnosis of chronic peri-prosthetic joint infection – a systematic review and meta-analysis” published in J. Bone Joint Infect., 10, 165–184, 2025&lt;/b&gt;&lt;br&gt;
                Marta Sabater-Martos, Benjamin Langworthy, Martin Clauss, Ana Ribau, Ricardo Sousa, and and on behalf of the Leukocyte Count Synovial Fluid working group for the Unified PJI definition task force&lt;br&gt;
                    J. Bone Joint Infect., 11, 687&#8211;704, https://doi.org/10.5194/jbji-11-687-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: Peri-prosthetic joint infection (PJI) is a significant complication of arthroplasty, lacking a single gold standard diagnostic test. Synovial fluid white blood cell (WBC) count and polymorphonuclear neutrophil (PMN) proportion are widely used diagnostic tools, but their optimal cutoffs remain unclear, particularly for chronic PJI. <strong>Material and methods</strong>: This systematic review and meta-analysis included 74 studies published between 2000 and 2024. Data on diagnostic performance (sensitivity, specificity, and diagnostic odds ratios &amp;#8211; DORs) of WBC count and PMN proportions were analysed. Sub-group analyses and heterogeneity assessments were performed, and optimal cutoffs for diagnostic accuracy were identified. <strong>Results</strong>: The meta-analysis revealed a WBC count summary DOR of 58.38 (95&amp;#8201;% CI &amp;#8211; confidence interval: 48.48&amp;#8211;70.32) with an area under the curve (AUC) of the summarized receiver operating characteristic curve of 0.952. The PMN proportion showed a DOR of 43.17 (95&amp;#8201;% CI: 35.31&amp;#8211;52.79) and an AUC of 0.941. Optimal diagnostic thresholds for chronic PJI were WBC count <span class="inline-formula">&amp;#8776;</span>&amp;#8201;1792&amp;#8201;cells&amp;#8201;mL<span class="inline-formula"><sup>&amp;#8722;1</sup></span&gt; (sensitivity 86&amp;#8201;%, specificity 87&amp;#8201;%) and PMN <span class="inline-formula">&amp;#8776;</span>&amp;#8201;67&amp;#8201;% (sensitivity 89&amp;#8201;%, specificity 86&amp;#8201;%). No single threshold reached <span class="inline-formula">&amp;#8805;</span>&amp;#8201;95&amp;#8201;% specificity or <span class="inline-formula">&amp;#8805;</span>&amp;#8201;95&amp;#8201;% sensitivity: specificity was <span class="inline-formula">&amp;#8776;</span>&amp;#8201;91&amp;#8201;% at WBC count <span class="inline-formula">&amp;#8805;</span>&amp;#8201;3000&amp;#8201;cells&amp;#8201;mL<span class="inline-formula"><sup>&amp;#8722;1</sup></span&gt; and <span class="inline-formula">&amp;#8776;</span>&amp;#8201;90&amp;#8201;% at PMN&amp;#8201;<span class="inline-formula">&amp;#8805;</span>&amp;#8201;75&amp;#8201;%, and sensitivity was <span class="inline-formula">&amp;#8776;</span>&amp;#8201;88&amp;#8201;%&amp;#8211;90&amp;#8201;% at WBC count <span class="inline-formula">&amp;#8804;</span>&amp;#8201;1500&amp;#8201;cells&amp;#8201;mL<span class="inline-formula"><sup>&amp;#8722;1</sup></span&gt; and PMN <span class="inline-formula">&amp;#8804;</span>&amp;#8201;65&amp;#8201;%. Confounding conditions such as fractures, inflammatory arthritis, and metal-related reactions reduced test accuracy. <strong>Conclusions</strong>: Synovial fluid analysis remains a critical diagnostic tool for chronic PJI. Lower thresholds (WBC count <span class="inline-formula">></span>&amp;#8201;1500&amp;#8201;cells&amp;#8201;mL<span class="inline-formula"><sup>&amp;#8722;1</sup></span>; PMN <span class="inline-formula">></span>&amp;#8201;65&amp;#8201;%) are most useful for raising suspicion of infection and upper thresholds (WBC count <span class="inline-formula">></span>3000&amp;#8201;cells&amp;#8201;mL<span class="inline-formula"><sup>&amp;#8722;1</sup></span>; PMN <span class="inline-formula">></span>&amp;#8201;75&amp;#8201;%) for supporting it, although as single markers neither reaches the <span class="inline-formula">&amp;#8805;</span>&amp;#8201;95&amp;#8201;% specificity. A standardized diagnostic framework is essential for addressing remaining controversies and ensuring consistent interpretation across clinical settings.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-11-10T23:19:49+01:00</published>
            <updated>2026-11-10T23:19:49+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-673-2026</id>
            <title type="html">Success of debridement, antibiotics, and implant retention for acute hematogenous periprosthetic joint infection: a systematic review and meta-analysis
            </title>
            <link href="https://doi.org/10.5194/jbji-11-673-2026"/>
            <summary type="html">
                &lt;b&gt;Success of debridement, antibiotics, and implant retention for acute hematogenous periprosthetic joint infection: a systematic review and meta-analysis&lt;/b&gt;&lt;br&gt;
                Sina Esmaeili, Mohammadreza Razzaghof, Mohammad Ayati Firoozabadi, and Seyed Mohammad Javad Mortazavi&lt;br&gt;
                    J. Bone Joint Infect., 11, 673&#8211;686, https://doi.org/10.5194/jbji-11-673-2026, 2026&lt;br&gt;
                We reviewed 49 studies to assess the effectiveness of debridement, antibiotics, and implant retention (DAIR) for acute hematogenous periprosthetic joint infections (PJIs) involving hip and knee implants. This approach controlled infection in about two-thirds of patients, with better results in more recent years. Outcomes were worse with <em>Staphylococcus aureus</em&gt; infection and delayed surgery. These findings support early diagnosis, prompt treatment, and careful patient selection.
            </summary>
            <content type="html">
                &lt;b&gt;Success of debridement, antibiotics, and implant retention for acute hematogenous periprosthetic joint infection: a systematic review and meta-analysis&lt;/b&gt;&lt;br&gt;
                Sina Esmaeili, Mohammadreza Razzaghof, Mohammad Ayati Firoozabadi, and Seyed Mohammad Javad Mortazavi&lt;br&gt;
                    J. Bone Joint Infect., 11, 673&#8211;686, https://doi.org/10.5194/jbji-11-673-2026, 2026&lt;br&gt;
                <p><strong>Background</strong>: Acute hematogenous periprosthetic joint infection after hip or knee arthroplasty is difficult to treat. The method of debridement, antibiotics, and implant retention&amp;#160;(DAIR) is widely used, but reported success rates vary, and predictors of failure remain unclear. <strong>Methods</strong>: We searched PubMed, Scopus, Web of Science, and Embase from inception through 26&amp;#160;November&amp;#160;2025 for studies reporting outcomes of DAIR in acute hematogenous periprosthetic joint infection. Two reviewers independently screened studies, extracted data, and assessed methodological quality using Joanna&amp;#160;Briggs Institute tools. The primary outcome was pooled treatment success. <strong>Results</strong>: Forty-nine studies were included in the qualitative synthesis. Reported success rates ranged from 20&amp;#8201;% to 100&amp;#8201;%, with a pooled success rate of 64.5&amp;#8201;% (95&amp;#8201;% confidence interval, 59.3&amp;#8201;%&amp;#8211;69.4&amp;#8201;%; <span class="inline-formula"><i>I</i><sup>2</sup>=72</span>&amp;#8201;%, <span class="inline-formula"><i>&amp;#964;</i><sup>2</sup>=0.44</span>) in the meta-analysis. This pooled estimate describes an average across heterogeneous cohorts and should not be used as a patient-specific prediction.&amp;#160;Success was higher in total hip arthroplasty than in total knee arthroplasty (69.4&amp;#8201;% vs.&amp;#160;63.2&amp;#8201;%). Outcomes improved over time, from 44.9&amp;#8201;% before&amp;#160;2010 to 68.7&amp;#8201;% in 2020&amp;#8211;2025. <i>Staphylococcus aureus</i&gt; infection and prolonged symptom duration before debridement were the most consistently reported predictors of treatment failure, whereas some included studies reported improved outcomes with modular component exchange. <strong>Conclusion</strong>: DAIR controls infection in about two-thirds of patients with acute hematogenous periprosthetic joint infection. Failure remains common, especially with <i>S.&amp;#160;aureus</i&gt; infection or delayed intervention, supporting early diagnosis, prompt surgery, and careful patient selection.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-11-09T23:19:49+01:00</published>
            <updated>2026-11-09T23:19:49+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-667-2026</id>
            <title type="html">Direct healthcare burden and costs of operatively managed prosthetic joint infection in a public hospital setting
            </title>
            <link href="https://doi.org/10.5194/jbji-11-667-2026"/>
            <summary type="html">
                &lt;b&gt;Direct healthcare burden and costs of operatively managed prosthetic joint infection in a public hospital setting&lt;/b&gt;&lt;br&gt;
                Matthew Condon, Malak Alwaheed, Jillian O'Carroll, and Alan Molloy&lt;br&gt;
                    J. Bone Joint Infect., 11, 667&#8211;672, https://doi.org/10.5194/jbji-11-667-2026, 2026&lt;br&gt;
                Prosthetic joint infection is a devastating and expensive complication of hip and knee arthroplasty. Public institutions equipped for emergency management of these cases treat both public and private arthroplasty patients, resulting in increased costs to the public healthcare system. We quantify overall and proportional costs, and discuss the causes and effects of this problem, as hospital wait lists and health costs should be controlled.&amp;#160;
            </summary>
            <content type="html">
                &lt;b&gt;Direct healthcare burden and costs of operatively managed prosthetic joint infection in a public hospital setting&lt;/b&gt;&lt;br&gt;
                Matthew Condon, Malak Alwaheed, Jillian O'Carroll, and Alan Molloy&lt;br&gt;
                    J. Bone Joint Infect., 11, 667&#8211;672, https://doi.org/10.5194/jbji-11-667-2026, 2026&lt;br&gt;
                <p>Prosthetic joint infection (PJI) following arthroplasty is associated with high morbidity and financial cost. Patients often undergo multiple complex procedures, prolonged inpatient stays and outpatient parenteral antibiotic therapy (OPAT). We aim to quantify the economic implications of the inpatient and OPAT costs of the management of private patients treated in the public healthcare system. Retrospective analysis of operative PJI cases between September 2020 and September 2025 was performed. Included patients were those who had primary total hip replacement (THR) or total knee replacement (TKR) for osteoarthritis or trauma. Data included inpatient stay, OPAT utilization, surgical procedures (debridement, antibiotics, and implant retention (DAIR); and revisions), and private/public status at index procedure. Costs were estimated using available Health Service Executive (HSE) information on operative costs and bed days. There were 40 operative PJI cases in our centre over the study period. There were 22 TKRs and 18 THRs. Eighteen had their initial surgery publicly, whereas 14 had their initial surgery privately. A total of 19 patients underwent DAIR while the rest underwent one or several revisions. Combined total length of stay was 1796 bed days. The operative PJI burden over that period was EUR&amp;#8201;5&amp;#8201;005&amp;#8201;339 (median EUR&amp;#8201;84&amp;#8201;232 per episode) or approximately EUR&amp;#8201;1&amp;#8201;000&amp;#8201;000&amp;#8201;yr<span class="inline-formula"><sup>&amp;#8722;1</sup></span>. Fourteen private patients treated in our centre had publicly funded treatment at an estimated cost of EUR&amp;#8201;1&amp;#8201;967&amp;#8201;270 over a 5-year period or EUR&amp;#8201;393&amp;#8201;454&amp;#8201;yr<span class="inline-formula"><sup>&amp;#8722;1</sup></span>. Operative PJI imposes a substantial clinical and financial burden. Private patients treated in public hospitals contribute to the total costs, raising the justification for private healthcare contributions to publicly treated complications arising after private procedures.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-11-04T23:19:49+01:00</published>
            <updated>2026-11-04T23:19:49+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-655-2026</id>
            <title type="html">Multi-regional debridement and staged reconstruction for fracture-related infection after intramedullary nailing
            </title>
            <link href="https://doi.org/10.5194/jbji-11-655-2026"/>
            <summary type="html">
                &lt;b&gt;Multi-regional debridement and staged reconstruction for fracture-related infection after intramedullary nailing&lt;/b&gt;&lt;br&gt;
                Xingyu Chen, Junyi Li, Yunan Li, Hangyu Li, Kehan Lv, Yueliang Zhu, Muguo Song, and Jian Shi&lt;br&gt;
                    J. Bone Joint Infect., 11, 655&#8211;665, https://doi.org/10.5194/jbji-11-655-2026, 2026&lt;br&gt;
                Late infection after intramedullary nailing can involve the fracture site, nail entry site, medullary canal, and screw tracts. In 47 patients, a staged protocol combining nail removal, multi-regional debridement, temporary cement placement, and later reconstruction achieved infection control and bone union in most patients.&amp;#160;
            </summary>
            <content type="html">
                &lt;b&gt;Multi-regional debridement and staged reconstruction for fracture-related infection after intramedullary nailing&lt;/b&gt;&lt;br&gt;
                Xingyu Chen, Junyi Li, Yunan Li, Hangyu Li, Kehan Lv, Yueliang Zhu, Muguo Song, and Jian Shi&lt;br&gt;
                    J. Bone Joint Infect., 11, 655&#8211;665, https://doi.org/10.5194/jbji-11-655-2026, 2026&lt;br&gt;
                <p>Late fracture-related infection (FRI) after intramedullary nailing may extend beyond the fracture site to involve the medullary canal, nail entry site, and locking screw tracts. This retrospective cohort study evaluated a staged protocol incorporating systematic multi-regional debridement of the entire nail-related infection pathway.</p&gt;        <p>We reviewed 47 patients treated between January 2017 and January 2025, all of whom had fracture nonunion and an interval of at least 3 months from the first documented confirmation of FRI to admission. Stage I included intramedullary nail removal; systematic multi-regional debridement of the fracture/nonunion site, nail entry site, entire medullary canal, and proximal and distal locking screw tracts; locking plate fixation; and temporary vancomycin-loaded polymethyl methacrylate cement placement for dead-space management and induced membrane formation. Definitive Stage II reconstruction included the removal of the temporary plate construct and cement, repeat debridement, bone grafting, and definitive fixation with a new internal locking plate after clinical and laboratory infection quiescence and intraoperative reassessment.</p&gt;        <p>The cohort included 21 tibial and 26 femoral cases, with a mean follow-up of 25.3&amp;#8201;<span class="inline-formula">&amp;#177;</span>&amp;#8201;14.1 months. Two patients had confirmed persistent infection requiring repeat debridement before definitive Stage II reconstruction. No confirmed recurrence or unplanned surgical debridement for suspected recurrence occurred after definitive reconstruction. Union after the index Stage II reconstruction was achieved in 44 of 47 patients (93.6&amp;#8201;%). The remaining three patients achieved union after further surgery, resulting in a final union rate of 100&amp;#8201;%. The mean times to radiographic union and full weight-bearing were 9.7&amp;#8201;<span class="inline-formula">&amp;#177;</span>&amp;#8201;2.1 and 11.3&amp;#8201;<span class="inline-formula">&amp;#177;</span>&amp;#8201;3.8 months, respectively. Median (interquartile range) WBC count, ESR, and CRP decreased from 7.2 (6.2&amp;#8211;9.0)&amp;#8201;<span class="inline-formula">&amp;#215;</span>&amp;#8201;10<span class="inline-formula"><sup>9</sup></span>&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>, 39.0 (12.5&amp;#8211;65.0)&amp;#8201;mm&amp;#8201;h<span class="inline-formula"><sup>&amp;#8722;1</sup></span>, and 26.5 (10.3&amp;#8211;43.2)&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span&gt; to 5.9 (5.0&amp;#8211;7.7)&amp;#8201;<span class="inline-formula">&amp;#215;</span>&amp;#8201;10<span class="inline-formula"><sup>9</sup></span>&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>, 17.0 (8.0&amp;#8211;29.5)&amp;#8201;mm&amp;#8201;h<span class="inline-formula"><sup>&amp;#8722;1</sup></span>, and 6.3 (3.7&amp;#8211;8.9)&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>, respectively. LEFS and SF-36 scores increased from 47.0 (37.0&amp;#8211;65.5) and 417.0 (335.0&amp;#8211;439.0) to 70.0 (61.0&amp;#8211;75.5) and 491.0 (480.0&amp;#8211;516.5), whereas VAS and SAS scores decreased from 4.0 (4.0&amp;#8211;4.0) and 45.0 (42.0&amp;#8211;50.0) to 1.0 (0.0&amp;#8211;1.0) and 32.0 (29.5&amp;#8211;37.0), respectively (all <span class="inline-formula"><i>p</i>&amp;#8804;0</span>.001). These findings support the feasibility of this staged protocol in selected patients with late post-intramedullary-nailing FRI and nonunion.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-10-29T23:19:49+01:00</published>
            <updated>2026-10-29T23:19:49+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-651-2026</id>
            <title type="html">Beyond the binary description of sinus tracts in periprosthetic joint infection
            </title>
            <link href="https://doi.org/10.5194/jbji-11-651-2026"/>
            <summary type="html">
                &lt;b&gt;Beyond the binary description of sinus tracts in periprosthetic joint infection&lt;/b&gt;&lt;br&gt;
                Irene K. Sigmund, Marjan Wouthuyzen-Bakker, Tristan Ferry, Ricardo Sousa, Daniel Pérez-Prieto, Alex Soriano, Volker Alt, Willem J. Metsemakers, Martin Clauss, and Rihard Trebse&lt;br&gt;
                    J. Bone Joint Infect., 11, 651&#8211;654, https://doi.org/10.5194/jbji-11-651-2026, 2026&lt;br&gt;
                Sinus tracts are currently classified as present or absent in PJI definitions. Although appropriate for diagnosis, this binary approach does not reflect the considerable heterogeneity encountered in clinical practice. This Viewpoint highlights characteristics that may determine sinus tract complexity and proposes a framework for future standardized characterization to better inform surgical decision-making and treatment outcomes.
            </summary>
            <content type="html">
                &lt;b&gt;Beyond the binary description of sinus tracts in periprosthetic joint infection&lt;/b&gt;&lt;br&gt;
                Irene K. Sigmund, Marjan Wouthuyzen-Bakker, Tristan Ferry, Ricardo Sousa, Daniel Pérez-Prieto, Alex Soriano, Volker Alt, Willem J. Metsemakers, Martin Clauss, and Rihard Trebse&lt;br&gt;
                    J. Bone Joint Infect., 11, 651&#8211;654, https://doi.org/10.5194/jbji-11-651-2026, 2026&lt;br&gt;
                <p>Current periprosthetic joint infection (PJI) definitions classify sinus tracts as present or absent. While this binary approach is appropriate for diagnosing PJI, it does not capture the heterogeneity of sinus tracts relevant to surgical decision-making. We propose that future studies explore a standardized characterization of sinus tract complexity to better inform surgical treatment.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-10-16T23:19:49+02:00</published>
            <updated>2026-10-16T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-635-2026</id>
            <title type="html">The co-occurrence of peri-prosthetic fracture and infection: a scoping review on current diagnostic principles, treatment and outcome
            </title>
            <link href="https://doi.org/10.5194/jbji-11-635-2026"/>
            <summary type="html">
                &lt;b&gt;The co-occurrence of peri-prosthetic fracture and infection: a scoping review on current diagnostic principles, treatment and outcome&lt;/b&gt;&lt;br&gt;
                Noémie Reinert, Laura Bessems, Martin Clauss, Nader Maai, Jolien Onsea, Georges Vles, Karl Stoffel, Willem-Jan Metsemakers, and Mario Morgenstern&lt;br&gt;
                    J. Bone Joint Infect., 11, 635&#8211;649, https://doi.org/10.5194/jbji-11-635-2026, 2026&lt;br&gt;
                Infected periprosthetic fractures are severe complications in orthopedic surgery with difficult management and high failure rates. This review of 32 studies (273 patients) found limited diagnostic reliability, frequent use of staged revision surgery, and high rates of recurrent infection (21&amp;#8201;%) and revision surgeries. Current evidence is sparse and inconsistent, highlighting the need for standardized diagnostics and larger-prospective studies.
            </summary>
            <content type="html">
                &lt;b&gt;The co-occurrence of peri-prosthetic fracture and infection: a scoping review on current diagnostic principles, treatment and outcome&lt;/b&gt;&lt;br&gt;
                Noémie Reinert, Laura Bessems, Martin Clauss, Nader Maai, Jolien Onsea, Georges Vles, Karl Stoffel, Willem-Jan Metsemakers, and Mario Morgenstern&lt;br&gt;
                    J. Bone Joint Infect., 11, 635&#8211;649, https://doi.org/10.5194/jbji-11-635-2026, 2026&lt;br&gt;
                <p><strong>Background</strong>: The co-occurrence of periprosthetic fractures and infection, referred to as infected periprosthetic fracture&amp;#160;(iPPF), represents a highly burdensome complication in orthopedic surgery. Management is challenging since not rarely treatment principles of prosthetic joint infections and fracture-related infections have to be combined. The aim of this scoping review was to map the current literature on management and outcome of iPPFs. <strong>Methods</strong>: A scoping review was conducted in accordance with PRISMA-ScR guidelines. Five major databases were systematically searched. Studies reporting on diagnostic principles and/or treatment strategies for iPPF around the hip and knee were included. Data were mapped regarding study design, diagnostic approaches, surgical strategies, and outcome. <strong>Results</strong>: A total of 32 studies comprising 273&amp;#160;patients with iPPFs were included; 8 addressed diagnostic strategies, and 24&amp;#160;reported on treatment and outcome. Diagnostic studies demonstrated limited reliability of serum inflammatory markers, and although synovial fluid analysis appeared most informative, optimal thresholds remain uncertain. Most treatment studies were small and heterogeneous. A staged surgical approach, predominantly two-stage revision, was reported in 83&amp;#8201;% of the included studies. Across nine studies reporting outcomes, mean infection eradication and recurrence rates were 76.1&amp;#8201;% and 22.3&amp;#8201;%, respectively. The majority of the studies (58.3&amp;#8201;%) described that additional surgeries were needed to cure infection. Fracture healing outcomes were inconsistently reported (bone healing in 4&amp;#160;out of 9&amp;#160;studies with 53/58&amp;#160;fractures, mean 91.4&amp;#8201;%). <strong>Conclusion</strong>: This scoping review demonstrates that management of iPPFs remains highly challenging, with high rates of recurrent infection and unplanned revision surgery. However, the reported quantitative outcome data represent descriptive summaries derived from heterogeneous, predominantly small observational studies and case series and should not be interpreted as definitive benchmarks for clinical outcomes. The current evidence base remains limited, highlighting the need for standardized diagnostic criteria, uniform outcome reporting, and well-designed prospective multicenter studies.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-10-14T23:19:49+02:00</published>
            <updated>2026-10-14T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-623-2026</id>
            <title type="html">Machine learning in diabetic-foot osteomyelitis: current applications, challenges, and future directions
            </title>
            <link href="https://doi.org/10.5194/jbji-11-623-2026"/>
            <summary type="html">
                &lt;b&gt;Machine learning in diabetic-foot osteomyelitis: current applications, challenges, and future directions&lt;/b&gt;&lt;br&gt;
                Farzad Pourghazi, Seyed Mohammad Amin Alavi, Francesco Petri, Takahiro Matsuo, Sergio Alvarez Mulett, Fabio Borgonovo, Andrea Gori, Michael E. Torchia, Aaron J. Tande, and Elie F. Berbari&lt;br&gt;
                    J. Bone Joint Infect., 11, 623&#8211;634, https://doi.org/10.5194/jbji-11-623-2026, 2026&lt;br&gt;
                Diabetic-foot bone infection is difficult to diagnose, and machine learning may help clinicians use clinical information and medical images. We reviewed studies that developed or evaluated these models for diabetic-foot osteomyelitis. Most focused on diagnosis using either clinical and laboratory information or imaging. No study combined these sources, and testing in new groups was uncommon. Future research should combine clinical information with imaging and test models in other groups.
            </summary>
            <content type="html">
                &lt;b&gt;Machine learning in diabetic-foot osteomyelitis: current applications, challenges, and future directions&lt;/b&gt;&lt;br&gt;
                Farzad Pourghazi, Seyed Mohammad Amin Alavi, Francesco Petri, Takahiro Matsuo, Sergio Alvarez Mulett, Fabio Borgonovo, Andrea Gori, Michael E. Torchia, Aaron J. Tande, and Elie F. Berbari&lt;br&gt;
                    J. Bone Joint Infect., 11, 623&#8211;634, https://doi.org/10.5194/jbji-11-623-2026, 2026&lt;br&gt;
                <p><strong>Background</strong>: Diabetic-foot osteomyelitis&amp;#160;(DFO) is a severe complication of diabetic-foot ulcers associated with delayed healing, amputation, and increased mortality. Machine learning&amp;#160;(ML) has increasingly been explored for diagnosis and clinical decision-making in diabetic-foot care; however, the current evidence specific to DFO has not been systematically synthesized. <strong>Methods</strong>: We performed systematic searches of MEDLINE, Embase, Scopus, and Web of Science for studies published between January&amp;#160;2000 and May&amp;#160;2026. Studies that developed or evaluated ML models for DFO diagnosis, prediction, or outcomes were included. Data extraction was performed using the CHARMS framework, reporting followed PRISMA&amp;#160;2020 and TRIPOD-SRMA recommendations, and methodological quality was evaluated using PROBAST&amp;#8201;<span class="inline-formula">+</span>&amp;#8201;AI. Due to considerable heterogeneity, narrative synthesis was performed. <strong>Results</strong>: A total of 10&amp;#160;studies published from&amp;#160;2022 to&amp;#160;2026 met the inclusion criteria. Five studies developed or evaluated ML&amp;#160;models with a direct DFO diagnostic endpoint, one additional study evaluated model explainability, and four evaluated complementary DFO-relevant diabetic-foot applications. Reported discrimination ranged from&amp;#160;0.879 to&amp;#160;0.998, but comparisons were limited by differences in clinical endpoints, reference standards, input modalities and validation strategies. Only one direct DFO model was externally validated, and no study developed a multimodal model combining clinical and imaging data. <strong>Conclusion</strong>: Current evidence is limited by heterogeneous methodologies, limited external validation, and inconsistent reporting despite promising discrimination reported by several models.</p&gt;        <p>Future studies should evaluate whether multimodal models integrating clinical and imaging data provide incremental value over unimodal approaches, with external validation, calibration, and clinical utility assessment before clinical implementation.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-10-13T23:19:49+02:00</published>
            <updated>2026-10-13T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-613-2026</id>
            <title type="html">High preoperative CONUT score is associated with treatment failure and mortality after surgery for acute periprosthetic joint infection: a single-centre retrospective cohort study
            </title>
            <link href="https://doi.org/10.5194/jbji-11-613-2026"/>
            <summary type="html">
                &lt;b&gt;High preoperative CONUT score is associated with treatment failure and mortality after surgery for acute periprosthetic joint infection: a single-centre retrospective cohort study&lt;/b&gt;&lt;br&gt;
                Víctor Otero-Naveiro, Blanca Ayuso-García, Silvia Pena-Paz, Ricardo Andrés Rión-Giraldo, María José García-Pais, and Alejandro López-Pardo Pardo&lt;br&gt;
                    J. Bone Joint Infect., 11, 613&#8211;622, https://doi.org/10.5194/jbji-11-613-2026, 2026&lt;br&gt;
                We studied patients treated surgically for acute infection around hip or knee joint replacements to see whether a simple blood-based score reflecting nutrition and immune status could help to predict outcomes. Patients with a high score had a greater risk of treatment failure and death during follow-up. These findings suggest that routine blood tests may help to identify vulnerable patients before surgery and support better risk assessment and clinical decision-making.
            </summary>
            <content type="html">
                &lt;b&gt;High preoperative CONUT score is associated with treatment failure and mortality after surgery for acute periprosthetic joint infection: a single-centre retrospective cohort study&lt;/b&gt;&lt;br&gt;
                Víctor Otero-Naveiro, Blanca Ayuso-García, Silvia Pena-Paz, Ricardo Andrés Rión-Giraldo, María José García-Pais, and Alejandro López-Pardo Pardo&lt;br&gt;
                    J. Bone Joint Infect., 11, 613&#8211;622, https://doi.org/10.5194/jbji-11-613-2026, 2026&lt;br&gt;
                <p><strong>Introduction:</strong&gt; Acute periprosthetic joint infection (PJI) is associated with substantial morbidity and mortality. The controlling nutritional status (CONUT) score combines serum albumin, total lymphocyte count, and total cholesterol, and may reflect host vulnerability. This study evaluated whether preoperative CONUT is associated with failure and mortality after surgery for acute PJI.</p&gt;        <p><strong>Methods:</strong&gt; We performed a single-centre retrospective cohort study of patients surgically treated for acute postoperative or acute haematogenous hip or knee PJI between 1 January 2013 and 30 November 2024. PJI was defined according to EBJIS criteria. CONUT was calculated from preoperative blood tests and dichotomised as low (<span class="inline-formula"><</span>&amp;#8201;5; normal to mild) or high (<span class="inline-formula">&amp;#8805;</span>&amp;#8201;5; moderate to severe). Outcomes were defined using an adapted MSIS-ORT classification as failure, total failure including death within 1 year, and overall mortality.</p&gt;        <p><strong>Results:</strong&gt; Of 169 screened patients, 59 were excluded for missing CONUT data and 90 were included; <span class="inline-formula"><math xmlns="http://www.w3.org/1998/Math/MathML" id="M3" display="inline" overflow="scroll" dspmath="mathml"><mrow><mn mathvariant="normal">42</mn><mo>/</mo><mn mathvariant="normal">90</mn></mrow></math><span><svg:svg xmlns:svg="http://www.w3.org/2000/svg" width="33pt" height="14pt" class="svg-formula" dspmath="mathimg" md5hash="0b584b208c06d0e4035333047ee31e3d"><svg:image xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jbji-11-613-2026-ie00001.svg" width="33pt" height="14pt" src="jbji-11-613-2026-ie00001.png"/></svg:svg></span></span&gt; (46.7&amp;#8201;%) had high CONUT. High CONUT was associated with higher failure (35.7&amp;#8201;% vs. 10.4&amp;#8201;%; <span class="inline-formula"><i>p</i>=0.004</span>), total failure (57.1&amp;#8201;% vs. 12.5&amp;#8201;%; <span class="inline-formula"><i>p</i><0.001</span>), and overall mortality (61.9&amp;#8201;% vs. 22.9&amp;#8201;%; <span class="inline-formula"><i>p</i><0.001</span>). Adjusted analyses confirmed independent associations with failure (odds ratio (OR) 4.24, 95&amp;#8201;% confidence interval (CI) 1.34&amp;#8211;13.46; <span class="inline-formula"><i>p</i>=0.014</span>), total failure (OR 9.57, 95&amp;#8201;% CI 2.91&amp;#8211;31.50; <span class="inline-formula"><i>p</i><0.001</span>), and overall mortality (hazard ratio (HR) 2.73, 95&amp;#8201;% CI 1.29&amp;#8211;5.74; <span class="inline-formula"><i>p</i>=0.008</span>).</p&gt;        <p><strong>Conclusions:</strong&gt; High preoperative CONUT was associated with failure, total failure, and overall mortality after surgery for acute PJI. It may support risk stratification but should not be viewed solely as a nutritional marker, as its components may reflect systemic inflammation, bacteraemia, and infection severity.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-10-13T23:19:49+02:00</published>
            <updated>2026-10-13T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-601-2026</id>
            <title type="html">Risk factors for treatment failure of surgical site  deep infections following spinal instrumentation: multicentre observational study (DeFEndO study)
            </title>
            <link href="https://doi.org/10.5194/jbji-11-601-2026"/>
            <summary type="html">
                &lt;b&gt;Risk factors for treatment failure of surgical site  deep infections following spinal instrumentation: multicentre observational study (DeFEndO study)&lt;/b&gt;&lt;br&gt;
                Renato Pascale, Mena Gallo, Nicolò Regge Gianas, Giacomo Fornaro, Irene Grassi, Manuel Zagarrigo, Andrea Grechi, Alberto Zuppiroli, Dario Santoro, Elena Tenti, Luca Boriani, Eleonora Zamparini, Alessandro Gasbarrini, Pierluigi Viale, Maddalena Giannella, Stefania Curti, and Sara Tedeschi&lt;br&gt;
                    J. Bone Joint Infect., 11, 601&#8211;611, https://doi.org/10.5194/jbji-11-601-2026, 2026&lt;br&gt;
                Deep infections after spinal surgery are serious complications requiring surgery and prolonged antibiotic therapy. In this study, we analysed 161 patients with deep surgical-site infections after spinal instrumentation to identify factors associated with treatment failure. Gram-negative infections seemed linked to worse outcomes, whereas quinolone use appeared to be associated with better results. Treatment duration (8 vs. 12 weeks) had no significant impact.
            </summary>
            <content type="html">
                &lt;b&gt;Risk factors for treatment failure of surgical site  deep infections following spinal instrumentation: multicentre observational study (DeFEndO study)&lt;/b&gt;&lt;br&gt;
                Renato Pascale, Mena Gallo, Nicolò Regge Gianas, Giacomo Fornaro, Irene Grassi, Manuel Zagarrigo, Andrea Grechi, Alberto Zuppiroli, Dario Santoro, Elena Tenti, Luca Boriani, Eleonora Zamparini, Alessandro Gasbarrini, Pierluigi Viale, Maddalena Giannella, Stefania Curti, and Sara Tedeschi&lt;br&gt;
                    J. Bone Joint Infect., 11, 601&#8211;611, https://doi.org/10.5194/jbji-11-601-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: To describe the characteristics and outcome of patients diagnosed with deep surgical-site infections following spinal instrumentation&amp;#160;(DSIIs) and to investigate risk factors for treatment failure including antimicrobial treatment duration as the main exposure. <strong>Materials and methods</strong>: An observational retrospective study on patients diagnosed with DSII from January&amp;#160;2018 to June&amp;#160;2022 in two large hospitals. Two multivariable analyses were carried out to evaluate risk factors for treatment failure considering two treatment schedules: 8-week versus 12-week. <strong>Results</strong>: We enrolled 161&amp;#160;patients, median age 62&amp;#160;years (IQR:&amp;#160;51&amp;#8211;69), 55.1&amp;#8201;% male, median Charlson comorbidity index of 3&amp;#160;(IQR:&amp;#160;1&amp;#8211;4). Gram-positive and Gram-negative bacteria were responsible for DSII in 60.3&amp;#8201;% and 33.8&amp;#8201;% of cases. Polymicrobial infections accounted for 42&amp;#160;cases (26.4&amp;#8201;%). Treatment failure was observed in&amp;#160;51 (31.7&amp;#8201;%) patients. Multivariable analyses were conducted to evaluate risk factors for treatment failure using treatment duration cutoffs of 8&amp;#160;weeks and 12&amp;#160;weeks. Quinolone administration was associated with a lower risk of treatment failure in both treatment schedules (8&amp;#160;weeks: OR&amp;#160;0.11, 95&amp;#8201;% CI&amp;#160;0.02&amp;#8211;0.71, <span class="inline-formula"><i>p</i>=0.020</span>; 12&amp;#160;weeks: OR&amp;#160;0.11, 95&amp;#8201;% CI&amp;#160;0.02&amp;#8211;0.64, <span class="inline-formula"><i>p</i>=0.015</span>). Gram-negative aetiology of DSII was a risk factor for treatment failure (8&amp;#160;weeks: OR&amp;#160;4.20, 95&amp;#8201;% CI&amp;#160;1.08&amp;#8211;16.38, <span class="inline-formula"><i>p</i>=0.039</span>; 12&amp;#160;weeks: OR&amp;#160;4.46, 95&amp;#8201;% CI&amp;#160;1.15&amp;#8211;17.23, <span class="inline-formula"><i>p</i>=0.030</span>). <strong>Conclusions</strong>: DSII caused by Gram-negative bacteria was associated with a higher risk of worse outcomes. Quinolone use appeared to be associated with a lower risk of treatment failure, but this finding should be interpreted with caution given the potential for residual confounding. No significant association between treatment duration and outcome was observed in our exploratory analyses.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-10-06T23:19:49+02:00</published>
            <updated>2026-10-06T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-591-2026</id>
            <title type="html">External validation of the KLIC score and development  of a novel prediction model for debridement, antibiotics, and implant retention failure in prosthetic joint  infection: a multicentre cohort study
            </title>
            <link href="https://doi.org/10.5194/jbji-11-591-2026"/>
            <summary type="html">
                &lt;b&gt;External validation of the KLIC score and development  of a novel prediction model for debridement, antibiotics, and implant retention failure in prosthetic joint  infection: a multicentre cohort study&lt;/b&gt;&lt;br&gt;
                Giulia Zumbo, Iris Martínez-Alemany, Jose Maria Bravo-Ferrer, Isabel Nieto Diaz De Los Bernardos, Julia Praena, Alfonso Del Arco, Enrique Nuño, Juan Enrique Corzo Delgado, Francisco Brun, Clara Natera, Alberto Romero Palacios, Beatriz Sobrino, Jesús Rodríguez-Baño, and María-Dolores del-Toro-López&lt;br&gt;
                    J. Bone Joint Infect., 11, 591&#8211;599, https://doi.org/10.5194/jbji-11-591-2026, 2026&lt;br&gt;
                <span data-olk-copy-source="MessageBody">Surgical debridement with implant retention (DAIR) fails in up to 55 % of prosthetic joint infections. In 224 patients, the Kidney, Liver, Index surgery, Cemented prosthesis and C-reactive protein (KLIC) score showed no discrimination of DAIR failure versus a new model (areas under the curve 0.53 vs 0.85), including comorbidity, C-reactive protein, revision prosthesis, time to surgery, and Gram-negative/polymicrobial infection. Three failure-risk groups were identified: 25.5 %, 45.6 %, and 87.9 %.</span>
            </summary>
            <content type="html">
                &lt;b&gt;External validation of the KLIC score and development  of a novel prediction model for debridement, antibiotics, and implant retention failure in prosthetic joint  infection: a multicentre cohort study&lt;/b&gt;&lt;br&gt;
                Giulia Zumbo, Iris Martínez-Alemany, Jose Maria Bravo-Ferrer, Isabel Nieto Diaz De Los Bernardos, Julia Praena, Alfonso Del Arco, Enrique Nuño, Juan Enrique Corzo Delgado, Francisco Brun, Clara Natera, Alberto Romero Palacios, Beatriz Sobrino, Jesús Rodríguez-Baño, and María-Dolores del-Toro-López&lt;br&gt;
                    J. Bone Joint Infect., 11, 591&#8211;599, https://doi.org/10.5194/jbji-11-591-2026, 2026&lt;br&gt;
                <p>Appropriate estimation of the risk of failure after debridement, antibiotics, and implant retention&amp;#160;(DAIR) may provide useful prognostic information in patients with prosthetic joint infection&amp;#160;(PJI). We aimed to externally validate the Kidney, Liver, Index surgery, Cemented prosthesis, C-reactive protein (KLIC) score and to develop and internally validate a new prediction model based on variables available before DAIR. We conducted a retrospective multicentre cohort study using medical record data from  adults with PJI treated with DAIR across eight Spanish centres between&amp;#160;2006 and&amp;#160;2023, with a minimum 12-month follow-up. Predictors were analysed using a generalized linear mixed-effects model, with assessment of discrimination, calibration, and bootstrap internal validation. Among 224 patients, 121&amp;#160;(54&amp;#8201;%) experienced DAIR failure. The final model retained revision prosthesis, Charlson Comorbidity Index&amp;#8201;<span class="inline-formula">&amp;#8805;</span>&amp;#8201;3, C-reactive protein&amp;#8201;<span class="inline-formula">></span>&amp;#8201;150&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>, longer time from index arthroplasty to DAIR, and Gram-negative bacilli or polymicrobial infection. The model showed good discrimination (Areas under the receiver operating characteristic curve (AUC-ROC)&amp;#160;0.85; 95&amp;#8201;% confidence interval (CI)&amp;#160;0.79&amp;#8211;0.90) and satisfactory calibration; the optimism-corrected AUC-ROC was&amp;#160;0.83. The derived clinical score showed an AUC-ROC of&amp;#160;0.81 (95&amp;#8201;% CI&amp;#160;0.75&amp;#8211;0.87) and identified groups with observed failure rates of 25.5&amp;#8201;%, 45.6&amp;#8201;%, and 87.9&amp;#8201;%. The KLIC score did not demonstrate discriminative ability beyond chance (AUC-ROC&amp;#160;0.53; 95&amp;#8201;% CI&amp;#160;0.44&amp;#8211;0.64). Excluding microbiological aetiology reduced discrimination to 0.81&amp;#160;for the multivariable model and 0.77&amp;#160;for the corresponding reduced score. The new model showed good discrimination and calibration in this cohort, but external validation in independent PJI-DAIR populations is required before clinical implementation can be recommended.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-10-02T23:19:49+02:00</published>
            <updated>2026-10-02T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-579-2026</id>
            <title type="html">Long-term outcomes of vascularized fibular grafting for infected non-union of the lower limb: a competing-risk analysis
            </title>
            <link href="https://doi.org/10.5194/jbji-11-579-2026"/>
            <summary type="html">
                &lt;b&gt;Long-term outcomes of vascularized fibular grafting for infected non-union of the lower limb: a competing-risk analysis&lt;/b&gt;&lt;br&gt;
                Anne Le Hir, Piseth Seng, David Delarbre, Romain Ambrosino, Najib Kachouh, Régis Legré, and Andreas Stein&lt;br&gt;
                    J. Bone Joint Infect., 11, 579&#8211;590, https://doi.org/10.5194/jbji-11-579-2026, 2026&lt;br&gt;
                Serious bone infections can stop broken bones from healing and may lead to limb loss. We studied 22 people treated with a transplant of living bone from another part of the body to save the affected limb. Almost three-quarters achieved bone healing and infection control, although recovery often took many months, and a few patients still required amputation. Some patients required an additional bone graft. Long-term follow-up is essential when evaluating this treatment.
            </summary>
            <content type="html">
                &lt;b&gt;Long-term outcomes of vascularized fibular grafting for infected non-union of the lower limb: a competing-risk analysis&lt;/b&gt;&lt;br&gt;
                Anne Le Hir, Piseth Seng, David Delarbre, Romain Ambrosino, Najib Kachouh, Régis Legré, and Andreas Stein&lt;br&gt;
                    J. Bone Joint Infect., 11, 579&#8211;590, https://doi.org/10.5194/jbji-11-579-2026, 2026&lt;br&gt;
                <p><strong>Background</strong>: Infected non-union of the lower limb is among the most challenging conditions in orthopedic surgery. Vascularized fibular grafting (VFG) is a limb-salvage option for large infected bone defects, but outcomes accounting for competing events remain poorly documented. <strong>Methods</strong>: We conducted a retrospective single-center study of adults treated consecutively with VFG for infected femoral or tibial non-union between 2014 and 2023. Infected non-union combined institutional non-union criteria with fracture-related infection as per international consensus definitions. Treatment success was defined as consolidation with infection remission. Amputation and death were competing events; cumulative incidence of consolidation was estimated using competing-risk methods. <strong>Results</strong>: A total of 22 patients were included (median age of 45 years). Consolidation was achieved in 17 patients (77&amp;#8201;%), infection remission was achieved in 16 (73&amp;#8201;%), and treatment success was achieved in 16 (73&amp;#8201;%): 9 (41&amp;#8201;%) after VFG alone and 7 (32&amp;#8201;%) after secondary bone grafting. Six patients (27&amp;#8201;%) had unfavorable outcomes: four amputations, one persistent non-union, and one death. The median time to consolidation was 14 months after VFG alone and 38 months after secondary grafting. Cumulative incidence of consolidation reached approximately 18&amp;#8201;% at 12 months, 41&amp;#8201;% at 24 months, 59&amp;#8201;% at 36 months, and 76&amp;#8201;% by end of follow-up. All seven patients undergoing secondary grafting for delayed consolidation ultimately achieved union; no formal comparative analysis was performed given the small, time-dependent sample. <strong>Conclusion</strong>: VFG is a valuable limb-salvage strategy for selected patients with infected non-union. Consolidation may occur late, underscoring the need for prolonged follow-up and competing-risk methodology. Findings should be interpreted given the retrospective design, small sample, and heterogeneous follow-up.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-09-15T23:19:49+02:00</published>
            <updated>2026-09-15T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-569-2026</id>
            <title type="html">Investigating long-term quality of life and depressive symptoms following fracture-related infection:  a systematic review with meta-analysis  of heterogeneous evidence
            </title>
            <link href="https://doi.org/10.5194/jbji-11-569-2026"/>
            <summary type="html">
                &lt;b&gt;Investigating long-term quality of life and depressive symptoms following fracture-related infection:  a systematic review with meta-analysis  of heterogeneous evidence&lt;/b&gt;&lt;br&gt;
                Johann Alexander Betker, Nike Walter, Markus Rupp, Susanne Baertl, and Volker Alt&lt;br&gt;
                    J. Bone Joint Infect., 11, 569&#8211;577, https://doi.org/10.5194/jbji-11-569-2026, 2026&lt;br&gt;
                An infected bone fracture can lead to long-lasting problems with movement, daily function, and mental well-being. A review of 15 studies found that physical recovery often stayed below normal even after 1 year or more. Overall mental quality of life seemed stable, but other tests showed signs of ongoing depression. The evidence was mixed and limited, therefore better long-term studies and regular psychological screening are needed.
            </summary>
            <content type="html">
                &lt;b&gt;Investigating long-term quality of life and depressive symptoms following fracture-related infection:  a systematic review with meta-analysis  of heterogeneous evidence&lt;/b&gt;&lt;br&gt;
                Johann Alexander Betker, Nike Walter, Markus Rupp, Susanne Baertl, and Volker Alt&lt;br&gt;
                    J. Bone Joint Infect., 11, 569&#8211;577, https://doi.org/10.5194/jbji-11-569-2026, 2026&lt;br&gt;
                <p><strong>Background</strong>: Fracture-related infection (FRI) is associated with prolonged treatment courses and functional impairment. However, the long-term effects of FRI on quality of life (QoL) and psychological outcomes remain unclear.</p&gt;        <p><strong>Methods</strong>: A PRISMA-compliant systematic review of PubMed, Web of Science, and Google Scholar for studies published from 2010 to August 2025 was performed. Methodological quality and bias were assessed with Methodological Index for Non-Randomised Studies (MINORS) and ROBINS-I. Where appropriate, data were synthesized using random-effects models and interpreted cautiously due to substantial heterogeneity.</p&gt;        <p><strong>Results</strong>: Fifteen studies met the inclusion criteria. The evidence base is dominated by retrospective cohorts: mean MINORS attainment 66.4&amp;#8201;% and mean loss to follow-up 19.5&amp;#8201;%. Meta-analysis of three studies (<span class="inline-formula"><i>n</i>=125</span>) showed non-significant mean changes at 12 months or more in SF-36 and SF-12 physical component score (PCS) of 5.81 (SD 6.54, <span class="inline-formula"><i>p</i>=0.124</span>) and 3.86, (9.12, <span class="inline-formula"><i>p</i>=0.463</span>) in the mental component (MCS).  Pooled long-term estimates from seven studies (<span class="inline-formula"><i>n</i>=262</span>) were 38.9 (2.18) for PCS and 51.2 (4.11) for MCS. Compared with US population norms, PCS was reduced, whereas differences in mental QoL were not significant. Three studies (<span class="inline-formula"><i>n</i>=118</span>) assessing psychological symptoms using the ISR reported elevated depressive symptom and total ISR scores exceeding established caseness thresholds.</p&gt;        <p><strong>Discussion</strong>: Current evidence suggests persistent physical and psychological burden after FRI treatment. However, heterogeneity, limited study quality, evolving FRI definitions, and a lack of appropriate comparison groups prevent definitive conclusions. Prospective studies using standardized outcome measures are required.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-09-14T23:19:49+02:00</published>
            <updated>2026-09-14T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-565-2026</id>
            <title type="html">Clinical case of polymicrobial and multidrug-resistant posttraumatic chronic hip infection treatment
            </title>
            <link href="https://doi.org/10.5194/jbji-11-565-2026"/>
            <summary type="html">
                &lt;b&gt;Clinical case of polymicrobial and multidrug-resistant posttraumatic chronic hip infection treatment&lt;/b&gt;&lt;br&gt;
                Urban Vadnjal, Samo Roškar, René Mihalič, Mitja Rak, and Rihard Trebše&lt;br&gt;
                    J. Bone Joint Infect., 11, 565&#8211;568, https://doi.org/10.5194/jbji-11-565-2026, 2026&lt;br&gt;
                The case demonstrates the importance of having well-established hospital algorithms for fracture related infection (FRI)/periprosthetic<br />joint infection (PJI) treatment and strictly following them at each step. In most severe cases related to multidrug-resistant (MDR) bacteria, a multiple-stage protocol is indicated, and intra-articular infusions of antibiotics should be considered in addition to standard intravenous regimens.
            </summary>
            <content type="html">
                &lt;b&gt;Clinical case of polymicrobial and multidrug-resistant posttraumatic chronic hip infection treatment&lt;/b&gt;&lt;br&gt;
                Urban Vadnjal, Samo Roškar, René Mihalič, Mitja Rak, and Rihard Trebše&lt;br&gt;
                    J. Bone Joint Infect., 11, 565&#8211;568, https://doi.org/10.5194/jbji-11-565-2026, 2026&lt;br&gt;
                <p>A 40-year-old man, after a left acetabular fracture, had eight surgeries, suffered from chronic multidrug-resistant infection with fistula, and underwent multi-stage hip revision surgery with spacer exchange and reconstruction, combined with systemic and intra-articular antibiotic therapy. He remained infection-free at 3.5-year follow-up.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-09-10T23:19:49+02:00</published>
            <updated>2026-09-10T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-555-2026</id>
            <title type="html">Sonication versus peri-implant tissue culture in fracture-related infection: diagnostic performance and therapeutic consequences in a single-center cohort
            </title>
            <link href="https://doi.org/10.5194/jbji-11-555-2026"/>
            <summary type="html">
                &lt;b&gt;Sonication versus peri-implant tissue culture in fracture-related infection: diagnostic performance and therapeutic consequences in a single-center cohort&lt;/b&gt;&lt;br&gt;
                Belal Abdo, Daniel Strack, Marcel Schäuffele, Tim Ludwig Tüngler, Can Imirzalioglu, Anita Windhorst, Moritz Fritzenwanker, Christian Heiss, and Markus Rupp&lt;br&gt;
                    J. Bone Joint Infect., 11, 555&#8211;563, https://doi.org/10.5194/jbji-11-555-2026, 2026&lt;br&gt;
                Fracture-related infections after bone surgery are difficult to diagnose because bacteria can attach to metal implants and become hard to detect, especially when antibiotics have already been given. We compared two laboratory methods used to identify bacteria on removed implants in 157 patients. Each method alone missed some infections, but using both together improved detection and helped guide antibiotic treatment. Our findings support combining diagnostic approaches to improve patient care.
            </summary>
            <content type="html">
                &lt;b&gt;Sonication versus peri-implant tissue culture in fracture-related infection: diagnostic performance and therapeutic consequences in a single-center cohort&lt;/b&gt;&lt;br&gt;
                Belal Abdo, Daniel Strack, Marcel Schäuffele, Tim Ludwig Tüngler, Can Imirzalioglu, Anita Windhorst, Moritz Fritzenwanker, Christian Heiss, and Markus Rupp&lt;br&gt;
                    J. Bone Joint Infect., 11, 555&#8211;563, https://doi.org/10.5194/jbji-11-555-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: Fracture-related infections (FRIs) represent a severe complication and pose diagnostic challenges due to biofilm-associated microorganisms. While peri-implant tissue culture (PTC) remains the standard, its sensitivity is limited. Sonication of explanted osteosynthesis material has been proposed as a complementary diagnostic tool; however, its contribution remains controversial. The aim of this study was to compare sonication and peri-implant tissue culture and their impact on antimicrobial management.</p&gt;        <p><strong>Methods</strong>: In this retrospective single-center study, all patients undergoing implant removal for FRI between 2016 and 2023 were screened. Cases with peri-implant tissue cultures and sonication fluid cultures (SFCs) were included. The diagnostic yield and pathogen spectrum of PTC and SFC were compared, including analyses in patients receiving antibiotic therapy. The impact of microbiological findings on antibiotic management was evaluated.</p&gt;        <p><strong>Results</strong>: Of 287 screened cases, 157 patients met the inclusion criteria. Pathogen detection was achieved in 60.5&amp;#8201;% using PTC and 57.3&amp;#8201;% using SFC. Incorporating both methods increased the diagnostic yield to 70.1&amp;#8201;%. Sonication identified additional pathogens in 17.8&amp;#8201;% of cases and PTC in 22.9&amp;#8201;%. Under antibiotic therapy, PTC demonstrated a slightly higher diagnostic yield than SFC. Antibiotic therapy was modified after revision surgery in 47.8&amp;#8201;% of cases, while sonication alone influenced treatment decisions in 4.5&amp;#8201;% of patients.</p&gt;        <p><strong>Conclusions</strong>: Neither PTC nor SFC alone achieved the diagnostic performance of their combined use. Combined testing improved diagnostic yield, supported targeted antimicrobial management, and reinforced the value of a multimodal microbiological approach to FRI.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-08-26T23:19:49+02:00</published>
            <updated>2026-08-26T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-547-2026</id>
            <title type="html">Periprosthetic fractures around chronically infected total hip arthroplasties: a case series and pragmatic two-stage treatment framework
            </title>
            <link href="https://doi.org/10.5194/jbji-11-547-2026"/>
            <summary type="html">
                &lt;b&gt;Periprosthetic fractures around chronically infected total hip arthroplasties: a case series and pragmatic two-stage treatment framework&lt;/b&gt;&lt;br&gt;
                Georges F. Vles, Willem-Jan Metsemakers, Laurens Aerden, Jan Geurts, Oliver Borens, and Stijn Ghijselings&lt;br&gt;
                    J. Bone Joint Infect., 11, 547&#8211;554, https://doi.org/10.5194/jbji-11-547-2026, 2026&lt;br&gt;
                We studied three patients who had both a broken femur and a long-standing infection around an artificial hip, a rare and difficult problem. We treated them in two steps: first removing the implant, cleaning the infection, stabilizing the bone, and placing a temporary bone cement spacer; and then reimplanting the hip prosthesis once infection was controlled. In all cases, the infection cleared, the bone healed, and function improved. This approach may offer a safe way to manage these complex cases.
            </summary>
            <content type="html">
                &lt;b&gt;Periprosthetic fractures around chronically infected total hip arthroplasties: a case series and pragmatic two-stage treatment framework&lt;/b&gt;&lt;br&gt;
                Georges F. Vles, Willem-Jan Metsemakers, Laurens Aerden, Jan Geurts, Oliver Borens, and Stijn Ghijselings&lt;br&gt;
                    J. Bone Joint Infect., 11, 547&#8211;554, https://doi.org/10.5194/jbji-11-547-2026, 2026&lt;br&gt;
                <p>Three periprosthetic femoral fractures around chronically infected total hip arthroplasties (THAs) were treated according to a pragmatic two-stage treatment framework. Infection control and fracture healing were achieved. This  may serve as a reference for surgeons confronted with these complex and technically demanding situations.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-08-25T23:19:49+02:00</published>
            <updated>2026-08-25T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-535-2026</id>
            <title type="html">Feasibility of a rat femoral-defect model for immediate perioperative and delayed post-implantation implant-associated bone infections
            </title>
            <link href="https://doi.org/10.5194/jbji-11-535-2026"/>
            <summary type="html">
                &lt;b&gt;Feasibility of a rat femoral-defect model for immediate perioperative and delayed post-implantation implant-associated bone infections&lt;/b&gt;&lt;br&gt;
                Pardis Keikhosravani, Michiel Croes, Nada Ristya Rahmani, Flurina Stabuli, Leonardo Cecotto, H. Charls Vogely, Bart C. H. van der Wal, Marianne Koolen, Debby Gawlitta, Harrie Weinans, Azin Khodaei, and Saber Amin Yavari&lt;br&gt;
                    J. Bone Joint Infect., 11, 535&#8211;546, https://doi.org/10.5194/jbji-11-535-2026, 2026&lt;br&gt;
                This study delivers a practical rat model for both early and delayed implant&amp;#8209;site infections. We show which bacterial doses and states produce consistent infections at each time point, creating a dependable platform to evaluate new materials and treatments that prevent or clear implant infections.&amp;#160;
            </summary>
            <content type="html">
                &lt;b&gt;Feasibility of a rat femoral-defect model for immediate perioperative and delayed post-implantation implant-associated bone infections&lt;/b&gt;&lt;br&gt;
                Pardis Keikhosravani, Michiel Croes, Nada Ristya Rahmani, Flurina Stabuli, Leonardo Cecotto, H. Charls Vogely, Bart C. H. van der Wal, Marianne Koolen, Debby Gawlitta, Harrie Weinans, Azin Khodaei, and Saber Amin Yavari&lt;br&gt;
                    J. Bone Joint Infect., 11, 535&#8211;546, https://doi.org/10.5194/jbji-11-535-2026, 2026&lt;br&gt;
                <p><strong>Background</strong>: Implant-associated bone infections (IAIs) represent a major clinical challenge, causing implant failure, prolonged morbidity, and costly revision surgeries. Infection risk is highest in the immediate perioperative period, but delayed post-implantation contamination, occurring weeks after surgery in a partially healed host, represents an equally important and underappreciated clinical scenario. Bacteria rapidly colonize implant surfaces and form biofilms that resist both antibiotics and host immune responses, making prevention critical. Well-characterized small-animal models that capture both early and delayed post-implantation infections are therefore essential to develop and test antibacterial implants and coatings. <strong>Methods</strong>: We developed a rat femoral-segmental-defect model stabilized with a polyether-ether-ketone plate and a 3D-printed porous titanium implant. Three studies were performed using a total of 28 animals (3 excluded due to early humane endpoints; <span class="inline-formula"><i>n</i>=25</span&gt; in final analysis): (i)&amp;#160;early inoculation during surgery with planktonic <i>Staphylococcus aureus</i&gt; (ATCC 49230) at 10<span class="inline-formula"><sup>4</sup></span&gt; or 10<span class="inline-formula"><sup>6</sup></span>&amp;#8201;CFU (colony-forming units) per rat, (ii)&amp;#160;delayed inoculation 28&amp;#8201;d after surgery with planktonic <i>S. aureus</i&gt; at 10<span class="inline-formula"><sup>4</sup></span&gt; or 10<span class="inline-formula"><sup>6</sup></span>&amp;#8201;CFU per rat, and (iii)&amp;#160;delayed inoculation with 10<span class="inline-formula"><sup>8</sup></span>&amp;#8201;CFU per rat delivered as planktonic or ruptured-biofilm inoculum. Controls received phosphate-buffered saline at implantation. The primary endpoint was infection at day 14, quantified by&amp;#8201;CFU enumeration from homogenized bone and from a sonicated implant, plate, and screws. Micro-computed tomography (micro-CT) was used to visualize fixation and hardware position. <strong>Results</strong>: Early inoculation with 10<span class="inline-formula"><sup>4</sup></span&gt; or 10<span class="inline-formula"><sup>6</sup></span>&amp;#8201;CFU per rat produced consistent infections across bone, implants, and screws. The same doses given 28&amp;#8201;d later yielded low and inconsistent colonization. Escalation to 10<span class="inline-formula"><sup>8</sup></span>&amp;#8201;CFU per rat in the delayed setting produced consistent infections; the ruptured-biofilm inoculum generated higher implant-associated bacterial burdens than planktonic suspensions, while bone burdens were consistently high in both arms. <strong>Conclusions</strong>: This femoral-implant rat model demonstrates feasibility for studying both immediate perioperative and delayed post-implantation infections, providing a platform for preclinical evaluation of anti-infection strategies. Timing, inoculum magnitude, and bacterial state critically determine infection establishment.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-08-25T23:19:49+02:00</published>
            <updated>2026-08-25T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-523-2026</id>
            <title type="html">Socioeconomic burden of septic re-revision surgeries for periprosthetic joint infections in Europe &#8211; a comprehensive analysis of re-revision costs
            </title>
            <link href="https://doi.org/10.5194/jbji-11-523-2026"/>
            <summary type="html">
                &lt;b&gt;Socioeconomic burden of septic re-revision surgeries for periprosthetic joint infections in Europe – a comprehensive analysis of re-revision costs&lt;/b&gt;&lt;br&gt;
                Dominik Szymski, Susanne Baertl, Nike Walter, Markus Rupp, Katja Hierl, and Volker Alt&lt;br&gt;
                    J. Bone Joint Infect., 11, 523&#8211;533, https://doi.org/10.5194/jbji-11-523-2026, 2026&lt;br&gt;
                A health-economic study estimating the cost of septic re-revision surgery for periprosthetic joint infections (PJIs) across 30 European countries. Using 2023 Eurostat data plus a 13-country reimbursement survey, the study estimates 22 794 PJIs and 8629 septic re-revisions in 2023, costing ~&amp;#8364;123.6 million (95% CI &amp;#8364;102&amp;#8211;156 million). Two-stage exchanges drive 82.8% of costs. Cutting PJI incidence by 25% could save &amp;#8364;27.9 million/year; shifting half of two-stage cases to one-stage a further &amp;#8364;22.6 million.
            </summary>
            <content type="html">
                &lt;b&gt;Socioeconomic burden of septic re-revision surgeries for periprosthetic joint infections in Europe – a comprehensive analysis of re-revision costs&lt;/b&gt;&lt;br&gt;
                Dominik Szymski, Susanne Baertl, Nike Walter, Markus Rupp, Katja Hierl, and Volker Alt&lt;br&gt;
                    J. Bone Joint Infect., 11, 523&#8211;533, https://doi.org/10.5194/jbji-11-523-2026, 2026&lt;br&gt;
                <p><strong>Introduction:</strong&gt; Periprosthetic joint infection (PJI) is a major cause of failure after total hip arthroplasty (THA) and total knee arthroplasty (TKA). While primary PJI treatment costs are increasingly recognized, the economic burden of septic re-revision surgery remains poorly defined. This study estimated septic re-revisions and the reimbursement burden across Europe. <strong>Methods:</strong&gt; A payor-perspective health-economic model was applied to 30 European countries, combining 2023 Eurostat arthroplasty data with published infection rates to estimate PJIs and septic re-revisions (including after aseptic revisions), categorized as DAIR (debridement, antibiotics, and implant retention), one-stage, or two-stage procedures. Reimbursement used 13-country survey data plus GDP-based extrapolation; sensitivity analyses varied key parameters by <span class="inline-formula">&amp;#177;</span>20&amp;#8201;%. <strong>Results:</strong&gt; In 2023, 2.29 million primary arthroplasties were performed in Europe, resulting in an estimated 22&amp;#8201;794 PJIs and 8629 septic re-revisions. Total reimbursement costs were estimated at EUR&amp;#8201;123.6 million (EUR&amp;#8201;74.1 million THA; EUR&amp;#8201;49.5 million TKA), split into EUR&amp;#8201;111.6 million after primary PJI treatment and EUR&amp;#8201;12.0 million after initially aseptic revision. Two-stage exchanges accounted for 82.8&amp;#8201;% of expenditures and were the main cost driver; Germany had the highest national costs. A Monte Carlo probabilistic sensitivity analysis yielded a 95&amp;#8201;% credibility interval of EUR&amp;#8201;102.0&amp;#8211;156.2 million. <strong>Conclusion:</strong&gt; Septic re-revision surgery after arthroplasty represents a substantial economic burden in Europe, largely driven by two-stage exchange procedures. Reducing infection and treatment failure rates may provide major clinical and financial benefits: a 25&amp;#8201;% reduction in PJI incidence could save EUR&amp;#8201;27.9 million annually (22.6&amp;#8201;%), and shifting half of two-stage cases to one-stage a further EUR&amp;#8201;22.6 million (18.3&amp;#8201;%).</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-08-24T23:19:49+02:00</published>
            <updated>2026-08-24T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-513-2026</id>
            <title type="html">Reinfection and complication rates in two-stage revision for chronic hip periprosthetic joint infections using the direct anterior approach
            </title>
            <link href="https://doi.org/10.5194/jbji-11-513-2026"/>
            <summary type="html">
                &lt;b&gt;Reinfection and complication rates in two-stage revision for chronic hip periprosthetic joint infections using the direct anterior approach&lt;/b&gt;&lt;br&gt;
                Sebastian Simon, Jennyfer A. Mitterer, Bernhard J. H. Frank, Stephanie Huber, Sujeesh Sebastian, Susana Gardete-Hartmann, and Jochen G. Hofstaetter&lt;br&gt;
                    J. Bone Joint Infect., 11, 513&#8211;521, https://doi.org/10.5194/jbji-11-513-2026, 2026&lt;br&gt;
                Two-stage septic revision was evaluated in 36 / 8476 (0.4 %) patients after primary total hip arthroplasty (THA) using the direct anterior approach (DAA). Infection-free survival was 77.8 % after a median follow-up of 6 years. Spacer-related complications occurred in 5.6 %. Revision for dislocation after reimplantation occurred in 8.3 %. Two-stage septic revision using the DAA shows reinfection rates comparable to other approaches, with low rates of spacer dislocation and postoperative dislocation after reimplantation.
            </summary>
            <content type="html">
                &lt;b&gt;Reinfection and complication rates in two-stage revision for chronic hip periprosthetic joint infections using the direct anterior approach&lt;/b&gt;&lt;br&gt;
                Sebastian Simon, Jennyfer A. Mitterer, Bernhard J. H. Frank, Stephanie Huber, Sujeesh Sebastian, Susana Gardete-Hartmann, and Jochen G. Hofstaetter&lt;br&gt;
                    J. Bone Joint Infect., 11, 513&#8211;521, https://doi.org/10.5194/jbji-11-513-2026, 2026&lt;br&gt;
                <p><strong>Introduction:</strong&gt; The direct anterior approach (DAA) used in primary total hip arthroplasty (THA) is gaining popularity and has infection rates comparable to other surgical approaches. While two-stage revision remains the gold standard for chronic periprosthetic joint infection (PJI), little data exist on the DAA. This study evaluated reinfection, and complication rates of two-stage septic revisions performed using the DAA.</p&gt;        <p><strong>Methods:</strong&gt; This retrospective single-center study included data from 8476 patients who underwent primary THA using the DAA between 2013 and 2024. All patients who underwent a two-stage procedure for chronic PJI were included. Clinical outcomes, complication rates, and microbiological spectrum were assessed. All patients received an antibiotic-loaded cement spacer at first stage, followed by antimicrobial therapy.</p&gt;        <p><strong>Results:</strong&gt; We identified 36&amp;#8201;<span class="inline-formula"><math xmlns="http://www.w3.org/1998/Math/MathML" id="M1" display="inline" overflow="scroll" dspmath="mathml"><mo>/</mo></math><span><svg:svg xmlns:svg="http://www.w3.org/2000/svg" width="8pt" height="14pt" class="svg-formula" dspmath="mathimg" md5hash="1b4178c77ca0d4bfee6c9ddd864f3a43"><svg:image xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jbji-11-513-2026-ie00001.svg" width="8pt" height="14pt" src="jbji-11-513-2026-ie00001.png"/></svg:svg></span></span>&amp;#8201;8476 (0.4&amp;#8201;%) patients (female: 41.7&amp;#8201;%, male: 58.3&amp;#8201;%) who underwent septic two-stage revision after primary DAA THA. Infection-free survival was 83.4&amp;#8201;% at a median 6.2-year follow-up. Successful second-stage reimplantation occurred in 28&amp;#8201;<span class="inline-formula"><math xmlns="http://www.w3.org/1998/Math/MathML" id="M2" display="inline" overflow="scroll" dspmath="mathml"><mo>/</mo></math><span><svg:svg xmlns:svg="http://www.w3.org/2000/svg" width="8pt" height="14pt" class="svg-formula" dspmath="mathimg" md5hash="527256ea34e0af356380afd605ccefc0"><svg:image xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jbji-11-513-2026-ie00002.svg" width="8pt" height="14pt" src="jbji-11-513-2026-ie00002.png"/></svg:svg></span></span>&amp;#8201;36 patients (77.8&amp;#8201;%), while 2&amp;#8201;<span class="inline-formula"><math xmlns="http://www.w3.org/1998/Math/MathML" id="M3" display="inline" overflow="scroll" dspmath="mathml"><mo>/</mo></math><span><svg:svg xmlns:svg="http://www.w3.org/2000/svg" width="8pt" height="14pt" class="svg-formula" dspmath="mathimg" md5hash="e653eaf840568ee76bb20ba3bf368ae0"><svg:image xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jbji-11-513-2026-ie00003.svg" width="8pt" height="14pt" src="jbji-11-513-2026-ie00003.png"/></svg:svg></span></span>&amp;#8201;36 (5.6&amp;#8201;%) remained infection free after a 1.5-stage procedure due to being clinically unfit for reimplantation. Four patients (11.1&amp;#8201;%) underwent a second stage but developed reinfection, requiring septic revision. Two patients (5.6&amp;#8201;%) had failed first stage and underwent a Girdlestone procedure. The reinfection rate was 11.1&amp;#8201;%, all culture positive at the second stage. Spacer-related complications occurred in 2&amp;#8201;<span class="inline-formula"><math xmlns="http://www.w3.org/1998/Math/MathML" id="M4" display="inline" overflow="scroll" dspmath="mathml"><mo>/</mo></math><span><svg:svg xmlns:svg="http://www.w3.org/2000/svg" width="8pt" height="14pt" class="svg-formula" dspmath="mathimg" md5hash="57ee8123d9c9aefcf23d9c7f6463c158"><svg:image xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jbji-11-513-2026-ie00004.svg" width="8pt" height="14pt" src="jbji-11-513-2026-ie00004.png"/></svg:svg></span></span>&amp;#8201;36 (5.6&amp;#8201;%), including one dislocation (2.8&amp;#8201;%) and one spacer fracture (2.8&amp;#8201;%). Revision for dislocation after the second stage was required in 3&amp;#8201;<span class="inline-formula"><math xmlns="http://www.w3.org/1998/Math/MathML" id="M5" display="inline" overflow="scroll" dspmath="mathml"><mo>/</mo></math><span><svg:svg xmlns:svg="http://www.w3.org/2000/svg" width="8pt" height="14pt" class="svg-formula" dspmath="mathimg" md5hash="93e47eb16cb371fe6916d3191efc4f1d"><svg:image xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jbji-11-513-2026-ie00005.svg" width="8pt" height="14pt" src="jbji-11-513-2026-ie00005.png"/></svg:svg></span></span>&amp;#8201;36 (8.3&amp;#8201;%). Patients with successful reimplantation were younger (<span class="inline-formula"><i>P</i><</span>0.001). Most common microorganisms were <i>Cutibacterium</i&gt; spp. (28.8&amp;#8201;%) and coagulase-negative <i>Staphylococci</i&gt; (26.9&amp;#8201;%).</p&gt;        <p><strong>Conclusions:</strong&gt; Two-stage septic revision using the DAA shows reinfection rates comparable to other approaches, with low rates of spacer dislocation and postoperative dislocation after reimplantation.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-08-19T23:19:49+02:00</published>
            <updated>2026-08-19T23:19:49+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-503-2026</id>
            <title type="html">Postoperative inflammatory markers and surgical wound infection after elective short-segment lumbar fusion: the importance of surgical context
            </title>
            <link href="https://doi.org/10.5194/jbji-11-503-2026"/>
            <summary type="html">
                &lt;b&gt;Postoperative inflammatory markers and surgical wound infection after elective short-segment lumbar fusion: the importance of surgical context&lt;/b&gt;&lt;br&gt;
                Jay Chung, Ta'ir Rocker, Regina Golding, Sachin Mehta, Madison McFarland, Arjun Gupta, Xiuyi Yang, Priya Singh, Evan Olsen, Shreya Balusu, Yungtai Lo, Pamela Zuckerman, Jeremy D. Shaw, and Mitchell S. Fourman&lt;br&gt;
                    J. Bone Joint Infect., 11, 503&#8211;511, https://doi.org/10.5194/jbji-11-503-2026, 2026&lt;br&gt;
                After elective short-segment lumbar fusion, inflammatory blood markers measured on the first postoperative day were strongly influenced by patient and operative factors. Day-three white blood cell count and the neutrophil-to-lymphocyte ratio showed exploratory associations with wound-related events, but these weakened after accounting for day-one values. The findings do not establish diagnostic thresholds and require prospective validation.
            </summary>
            <content type="html">
                &lt;b&gt;Postoperative inflammatory markers and surgical wound infection after elective short-segment lumbar fusion: the importance of surgical context&lt;/b&gt;&lt;br&gt;
                Jay Chung, Ta'ir Rocker, Regina Golding, Sachin Mehta, Madison McFarland, Arjun Gupta, Xiuyi Yang, Priya Singh, Evan Olsen, Shreya Balusu, Yungtai Lo, Pamela Zuckerman, Jeremy D. Shaw, and Mitchell S. Fourman&lt;br&gt;
                    J. Bone Joint Infect., 11, 503&#8211;511, https://doi.org/10.5194/jbji-11-503-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: Postoperative white blood cell (WBC) count and neutrophil-to-lymphocyte ratio (NLR) are routinely available after lumbar fusion, but early elevations may reflect surgical stress. We evaluated associations of postoperative day (POD) 1 and POD3 WBC/NLR with 90&amp;#8201;d surgical wound infection (SWI) after elective short-segment lumbar fusion. <strong>Methods</strong>: This retrospective cohort included adults undergoing elective one- to three-level lumbar fusion from 2022 to 2024 at one academic center. SWI was a pragmatic electronic-health-record-based endpoint encompassing clinically documented wound-related events, not a uniformly culture-confirmed deep, implant-associated, or surveillance-defined infection. Complete-case univariable and parsimoniously adjusted logistic regressions examined WBC/NLR associations with SWI. <strong>Results</strong>: Among 380 outcome-eligible patients, 18 (4.7&amp;#8201;%) developed SWI. POD1 analyses included 368 patients (18 events), POD3 analyses 336 (17 events), and paired analyses 327 (17 events). After adjustment for body mass index and operative duration, POD1 associations were attenuated; POD3 WBC (odds ratio 1.17, 95&amp;#8201;% confidence interval 1.00&amp;#8211;1.37; <span class="inline-formula"><i>p</i>=0.049</span>) and NLR (odds ratio 1.12, 95&amp;#8201;% confidence interval 1.01&amp;#8211;1.23; <span class="inline-formula"><i>p</i>=0.026</span>) remained associated with SWI. However, these associations weakened after adjustment for corresponding POD1 values. Absolute and percentage POD1-to-POD3 changes were not significantly associated with SWI. <strong>Conclusions</strong>: POD1 WBC/NLR elevations were associated with patient and operative context. POD3 values showed exploratory associations with SWI after limited adjustment but did not establish diagnostic thresholds, clinical utility, or a validated prediction model.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-08-18T23:19:49+02:00</published>
            <updated>2026-08-18T23:19:49+02:00</updated>
        </entry>
</feed>